Calendar AB Science

Equities

Market Closed - Euronext Paris Other stock markets 16:38:58 29/04/2024 BST			After market 19:32:37
1.96 ^EUR	+1.24%		1.958	-0.10%

04-04	AB Science's Reconsideration Request for ALS Treatment Granted Eligibility in Canada	MT
04-03	AB Science: reconsideration possible for masitinib in ALS	CF

373cda.hbP4VI_AgaRWnl-TuXtkpeS-U_ccPQJtLqC1bckV5_g.9tiSB86xycYl6gzJ7z434LTHBqhSRzcKS5DjF49wrtXJirxjvqfU0jzcPA~c14f4da128cb26f57f94ab4d27131e72

29/04/2024	Q4 2023 Earnings Release
29/09/2024	Q2 2024 Earnings Release
05/05/2025	Q4 2024 Earnings Release (Projected)
05/10/2025	Q2 2025 Earnings Release (Projected)
04/05/2026	Q4 2025 Earnings Release (Projected)
04/10/2026	Q2 2026 Earnings Release (Projected)

04/03/2024 17:30	Business Update Call
30/11/2023 14:00	Business Update Call
29/09/2023 18:49	Q2 2023 Earnings Release
30/06/2023 14:30	Annual General Meeting
15/05/2023	ALS Drug Development Summit
28/04/2023 17:41	Q4 2022 Earnings Release
16/03/2023 17:00	AB8939 Phase 1/2 Study Results Call
30/09/2022 17:39	Interim 2022 Earnings Release
23/05/2022	ALS Drug Development Summit
29/04/2022 17:33	FY 2021 Earnings Release
28/02/2022 17:00	Business Update Call
06/12/2021	International Symposium on ALS/MND
30/09/2021 18:21	Interim 2021 Earnings Release
11/09/2021	American Urological Association Meeting - Study AB12003
29/07/2021 15:00	Alzheimers Association International Conference
29/06/2021	Shareholders Meeting
04/06/2021 14:00	American Society of Clinical Oncology Conference
03/06/2021 17:30	Masitinib Clinical Study Suspension Call
25/05/2021 17:30	Investor Meeting - Key Opinion Leader
30/04/2021 17:45	FY 2020 Earnings Release

Fiscal Period	December	2018	2019	2020	2022	2023
Net sales Million EUR	Released Forecast Spread	1,70	1,57 1,55 1.65%	1,58	0,00	0,93
EBITDA Million EUR	Released Forecast Spread	0,00	0,00 0,00 -	0,00	0,00	-19,1
EBIT Million EUR	Released Forecast Spread	0,00	-17,5 -21,4 18.17%	0,00	0,00	-16,0
Earnings before Tax (EBT)	Released Forecast Spread	0,00	0,00 0,00 -	0,00	0,00	0,00
Net income Million EUR	Released Forecast Spread	0,00	0,00 0,00 -	0,00	-13,6	-19,6
EPS EUR	Released Forecast Spread	0,00	0,00 0,00 -	0,00	-0,29	-0,38
Announcement Date		30/04/19	30/04/20	30/04/21	01/03/23	-

Fiscal Period	December	2019 S1	2019 S2	2020 S1
Net sales Million EUR	Released Forecast Spread	0,79 0,70 13%	0,78 0,80 -2.5%	0,81 0,90 -10.33%
EBIT Million EUR	Released Forecast Spread	-10,6 -14,6 27.54%	-6,90 -10,8 36%
Announcement Date		30/09/19	30/04/20	30/09/20

29/04/2024	YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release
29/04/2024	SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
05/05/2024	HK INNO.N CORPORATION: Q1 2024 Earnings Release (Projected)
06/05/2024	KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
06/05/2024	KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release
06/05/2024	CALLIDITAS THERAPEUTICS AB: Q1 2024 Earnings Release
08/05/2024 21:05	SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
08/05/2024	SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
09/05/2024	OSCOTEC INC.: Q1 2024 Earnings Release (Projected)
12/05/2024	MEZZION PHARMA CO.,LTD.: Q1 2024 Earnings Release (Projected)

Today	FRONTIER BIOTECHNOLOGIES INC.: Q1 2024 Earnings Release (Projected)
Today	SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
25/04/2024	SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
25/04/2024	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024	JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024	YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q1 2024 Earnings Release (Projected)
25/04/2024	JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
25/04/2024 07:00	INDIVIOR PLC: Q1 2024 Earnings Release
24/04/2024	CHANGCHUN BCHT BIOTECHNOLOGY CO.: Q1 2024 Earnings Release (Projected)
23/04/2024	SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)